Drug Type Small molecule drug |
Synonyms RG NAE005, RG NAH005, RGNAE005 |
Target |
Action agonists |
Mechanism NR2F6 agonists(NR2F6 protein agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammatory Bowel Diseases | Preclinical | United States | 04 Oct 2018 | |
Autoimmune Diseases | Preclinical | United States | - |